Format

Send to

Choose Destination
See comment in PubMed Commons below
Trends Mol Med. 2013 Sep;19(9):565-82. doi: 10.1016/j.molmed.2013.05.007. Epub 2013 Jul 4.

Immunologically augmented cancer treatment using modern radiotherapy.

Author information

  • 1GSI Helmholtzzentrum für Schwerionenforschung, Biophysics Department, Darmstadt, Germany; Technische Universität Darmstadt, Darmstadt, Germany. Electronic address: M.Durante@gsi.de.

Abstract

Radiation oncology has recently seen tremendous technical advances, resulting in increasing cancer cures. However, malignant neoplasias are systemic diseases and may be lethal even with an excellent tumor local control. Immune therapy has grown to a mature approach in oncology, delivering results impossible only a few years ago. Treatment-limiting mechanisms such as the immune suppressive tumor microenvironment are now to a large extent deciphered, allowing for pharmacological intervention. Interestingly, radiation-based treatment effects have been shown to depend to a large degree on the immune system. Applying the recent advances in radiation therapy in conjunction with immune therapy can be a turning point towards the long-standing aim of curing cancer. Only a detailed understanding of the molecular mechanisms can guide the implementation of combined therapy modalities.

Copyright © 2013 Elsevier Ltd. All rights reserved.

KEYWORDS:

abscopal effects; combined treatments; immunotherapy; radiotherapy

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk